These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20347967)

  • 21. Endogenous Ouabain: Recent Advances and Controversies.
    Hamlyn JM; Blaustein MP
    Hypertension; 2016 Sep; 68(3):526-32. PubMed ID: 27456525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensational site: the sodium pump ouabain-binding site and its ligands.
    Blaustein MP; Hamlyn JM
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1120-C1177. PubMed ID: 38223926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous Mammalian Cardiotonic Steroids-A New Cardiovascular Risk Factor?-A Mini-Review.
    Słabiak-Błaż N; Piecha G
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotonic steroids in adaptation to dietary salt intake.
    Dial L; Liu J; Shapiro JI
    Curr Clin Pharmacol; 2014; 9(3):298-309. PubMed ID: 24219001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
    Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
    Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways.
    Kennedy DJ; Khalaf FK; Sheehy B; Weber ME; Agatisa-Boyle B; Conic J; Hauser K; Medert CM; Westfall K; Bucur P; Fedorova OV; Bagrov AY; Tang WHW
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30158457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous ouabain in renal Na(+) handling and related diseases.
    Manunta P; Messaggio E; Casamassima N; Gatti G; Carpini SD; Zagato L; Hamlyn JM
    Biochim Biophys Acta; 2010 Dec; 1802(12):1214-8. PubMed ID: 20226856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Na/K-ATPase endocytosis couples pumping and leaking activities in renal epithelial cells: a hypothesis.
    Liu J
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):97-104. PubMed ID: 17535743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiotonic Steroids-A Possible Link Between High-Salt Diet and Organ Damage.
    Paczula A; Wiecek A; Piecha G
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Na+]i/[K+]i -independent death of ouabain-treated renal epithelial cells is not mediated by Na+,K+ -ATPase internalization and de novo gene expression.
    Akimova OA; Hamet P; Orlov SN
    Pflugers Arch; 2008 Jan; 455(4):711-9. PubMed ID: 17622553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of dietary salt in hypertension.
    Haddy FJ
    Life Sci; 2006 Sep; 79(17):1585-92. PubMed ID: 16828490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced pressor response to increased CSF sodium concentration and to central ANG I in heterozygous alpha2 Na+ -K+ -ATPase knockout mice.
    Hou X; Theriault SF; Dostanic-Larson I; Moseley AE; Lingrel JB; Wu H; Dean S; Van Huysse JW
    Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1427-38. PubMed ID: 19244589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in understanding the role of cardiac glycosides in control of sodium transport in renal tubules.
    Khundmiri SJ
    J Endocrinol; 2014 Jul; 222(1):R11-24. PubMed ID: 24781255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium transport in the choroid plexus and salt-sensitive hypertension.
    Amin MS; Reza E; Wang H; Leenen FH
    Hypertension; 2009 Oct; 54(4):860-7. PubMed ID: 19635991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of renal function and structure by the signaling Na/K-ATPase.
    Xie JX; Li X; Xie Z
    IUBMB Life; 2013 Dec; 65(12):991-8. PubMed ID: 24323927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors.
    Hamlyn JM
    Front Endocrinol (Lausanne); 2014; 5():199. PubMed ID: 25520702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Na+,K+-ATPase as a Target for Treatment of Tissue Fibrosis.
    Orlov SN; La J; Smolyaninova LV; Dulin NO
    Curr Med Chem; 2019; 26(3):564-575. PubMed ID: 28625151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1254-8. PubMed ID: 20083196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase.
    Lingrel JB
    Annu Rev Physiol; 2010; 72():395-412. PubMed ID: 20148682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.